Sulfonamide lactam inhibitors of FXa and method

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S349000, C514S326000, C546S207000, C546S218000

Reexamination Certificate

active

10374299

ABSTRACT:
Sulfonamide lactams of the following formulawherein X, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R7and R8are as described herein, are provided which inhibitors of Factor Xa and are useful as anticoagulants in the treatment of cardiovascular diseases associated with thromboses.

REFERENCES:
patent: 5164388 (1992-11-01), De et al.
patent: 5489583 (1996-02-01), Mack et al.
patent: 5502032 (1996-03-01), Haupt et al.
patent: 5541343 (1996-07-01), Himmelsbach et al.
patent: 5591769 (1997-01-01), Himmelsbach et al.
patent: 5612353 (1997-03-01), Ewing et al.
patent: 5714499 (1998-02-01), Semple et al.
patent: 5719296 (1998-02-01), Acton, III et al.
patent: 5932733 (1999-08-01), Semple et al.
patent: 5981490 (1999-11-01), Baxter et al.
patent: 6034215 (2000-03-01), Semple et al.
patent: 6136834 (2000-10-01), Ohmoto et al.
patent: 6281227 (2001-08-01), Choi-Sledeski et al.
patent: 0519433 (1992-06-01), None
patent: 09165370 (1997-06-01), None
patent: WO89/10961 (1989-11-01), None
patent: WO90/04917 (1990-05-01), None
patent: WO90/05531 (1990-05-01), None
patent: WO92/10509 (1992-06-01), None
patent: WO92/10510 (1992-06-01), None
patent: WO93/01208 (1993-01-01), None
patent: WO95/35311 (1995-12-01), None
patent: WO95/35313 (1995-12-01), None
patent: WO96/40679 (1996-12-01), None
patent: WO97/14417 (1997-04-01), None
patent: WO97/30073 (1997-08-01), None
patent: WO97/31937 (1997-09-01), None
patent: WO97/31939 (1997-09-01), None
patent: WO98/00401 (1998-01-01), None
patent: WO98/08840 (1998-03-01), None
patent: WO98/16523 (1998-04-01), None
patent: WO98/46220 (1998-10-01), None
patent: WO98/47876 (1998-10-01), None
patent: WO98/50420 (1998-11-01), None
patent: WO00/05243 (2000-03-01), None
patent: WO00/44733 (2000-08-01), None
patent: WO01/19795 (2001-03-01), None
Biochemistry, 1998, 37(35), 12094-12103.
J. Med. Chem. 1993, 36, 300-303.
Goodman and Gilman's “The Pharmacological Basis of Therapeutics”, 10th Ed., 1996, pp. 54-57.
Siev, et al. (2000) Organic Letters vol. 2, No. 1, pp. 19-22.
Ewing et al., (1999) J. Med. Chem. vol. 42, pp. 3557-3571.
Reiner et al., (1999) Bioorganic & Medicinal Chemistry Letters 9, pp. 895-900.
Owens et al., (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 3683-3688.
Semple, J. Edward (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 2501-2506.
Nutt, et al., (1996) Peptides, pp. 71-74.
Semple, J. Edward (1998) Tetrahedron Letters 39, pp. 6645-6648.
Krishnan, et al. (1998) Biochemistry, vol. 37, pp. 12094-12103.
Semple et al., (1997) Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 18, pp. 2421-2426.
Klingler et al., (1997) Biophysical Journal, vol. 73, pp. 2195-2200.
Levy et al., (1996) Journal of Medicinal Chemistry, vol. 39, No. 23, pp. 4527-4530.
Semple et al., (1996) J. Med. Chem., vol. 39, pp. 4531-4536.
Okayama et al., (1995) Chem. Pharm. Bull., vol. 43, No. 10, pp. 1683-1691.
Mack et al., (1995) J. Enzyme Inhibition, vol. 9, pp. 73-86.
Tamura et al., (1997) Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 3, pp. 331-336.
Semple et al., (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 3525-3530.
Semple et al. (2000) Organic Letters, vol. 2, No. 18, pp. 2769-2772.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfonamide lactam inhibitors of FXa and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonamide lactam inhibitors of FXa and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide lactam inhibitors of FXa and method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3733826

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.